OC
EVH icon

Oppenheimer & Co’s Evolent Health EVH Stock Holding History

Oppenheimer & Co’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,222
Closed -$855K – 1583
2024
Q3 		$855K Buy
+30,222
New +$779K 0.01% 848
2024
Q2 		– Sell
-13,995
Closed -$459K – 1458
2024
Q1 		$459K Buy
+13,995
New +$447K 0.01% 1023
2023
Q2 		– Sell
-6,360
Closed -$206K – 1431
2023
Q1 		$206K Buy
+6,360
New +$201K ﹤0.01% 1256
2022
Q4 		– Sell
-6,454
Closed -$232K – 1378
2022
Q3 		$232K Buy
+6,454
New +$227K 0.01% 1161
2022
Q2 		– Sell
-6,360
Closed -$206K – 1452
2022
Q1 		$206K Buy
+6,360
New +$167K ﹤0.01% 1340
2021
Q2 		– Sell
-31,000
Closed -$626K – 1526
2021
Q1 		$626K Hold
31,000
– – 0.01% 874
2020
Q4 		$497K Hold
31,000
– – 0.01% 886
2020
Q3 		$385K Hold
31,000
– – 0.01% 895
2020
Q2 		$221K Sell
31,000
-18,060
-37% -$121K 0.01% 1077
2020
Q1 		$266K Buy
49,060
+5,000
+11% +$44.7K 0.01% 939
2019
Q4 		$399K Sell
44,060
-48,414
-52% -$393K 0.01% 926
2019
Q3 		$665K Buy
92,474
+2,847
+3% +$20.4K 0.02% 704
2019
Q2 		$712K Buy
89,627
+5,324
+6% +$63K 0.02% 694
2019
Q1 		$1.06M Sell
84,303
-15,585
-16% -$247K 0.03% 571
2018
Q4 		$1.99M Buy
99,888
+40,395
+68% +$935K 0.06% 338
2018
Q3 		$1.69M Buy
59,493
+3,456
+6% +$82.4K 0.04% 446
2018
Q2 		$1.18M Buy
56,037
+9,091
+19% +$172K 0.03% 533
2018
Q1 		$669K Buy
+46,946
New +$672K 0.02% 747

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Oppenheimer & Co's EVH Position: Q4 2024 in Review

Oppenheimer & Co sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 30,222 shares — an estimated $855K sold.

Oppenheimer & Co first reported a position in EVH in Q1 2018 and held it in 18 quarters. The position peaked at $1.99M in Q4 2018. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Oppenheimer & Co reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 30,222 Evolent Health shares in Q4 2024, an estimated $855K.
  • Oppenheimer & Co first reported a position in Evolent Health in Q1 2018 and held it in 18 quarters.
  • Oppenheimer & Co's Evolent Health position peaked at $1.99M in Q4 2018.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.